NSE filing, NSE: NRBBEARING. Summary written from the filing by ALFA Finder's alert engine.
NRB Bearings Ltd: key numbers
- Share price
- ₹454.35
- Market cap
- ₹4,404 Cr
- Revenue (annual)
- ₹1,335 Cr
- Net profit (annual)
- ₹142.8 Cr
- P/E (TTM)
- 29.9×Sector 52.0×
- Promoter holding
- 43.88%-0.85% QoQ
- FII holding
- 18.65%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from NRB Bearings Ltd
All →NRB Bearings Merger & Restructuring Worth ₹0.74 Cr
NRB Bearing Limited will sell 1.30% stake (7,36,000 shares) in Amplus Ampere Private Limited to Deepak Novochem Technologies Limited for ₹0.74 Crore.
- Value
- ₹0.74 Cr
NRB Bearings Merger & Restructuring Worth ₹0.72 Cr
NRB Bearings Limited entered an agreement to sell 7,20,000 equity shares in Amplus Ampere Private Limited. This transaction reduces the company's allocated captive solar capacity.
- Value
- ₹0.72 Cr
NRB Bearings Merger & Restructuring Worth ₹1.46 Cr
NRB Bearings Limited entered into agreements to divest its stake in Amplus Ampere Private Limited to Apcotex Industries Limited and Deepak Novochem Technologies Limited for ₹1.46 Crore.
- Value
- ₹1.46 Cr
NRB Bearings Other Announcement
NRB Bearings Ltd has submitted its quarterly shareholding pattern under Regulation 31(1)(b) of the SEBI (LODR) Regulations for the quarter ended September 30, 2026.
NRB Bearings Share Pledge
Promoter Harshbeena Zaveri sold shares (Rs.2.44 Cr) and released 9 lakh shares from pledge (Rs.48.12 Cr). This PIT disclosure updates promoter shareholding and encumbrance status.
- Value
- ₹50.56 Cr
NRB Bearings Share Pledge
Promoter Harshbeena Sahney Zaveri released a pledge of 900,000 equity shares of NRB Bearings Limited. This unpledge action reduces the total encumbered promoter stake.
Other other announcement announcements
All →Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.
Avience Biomedicals Other Announcement
Avience Biomedicals confirmed corporate governance compliance is not applicable, as it is SME-listed on NSE Emerge. No quarterly governance report is required for September 2026.